Elizabeth Woo
Keine laufenden Positionen mehr
Profil
Elizabeth Woo worked as an Investor Relations Officer at Biogen, Inc. from 1998 to 2009.
She then worked as a Senior Vice President of Investor and Public Relations at Poxel SA. In 2015, she worked as a Senior Vice President of Investor Relations at Flex Pharma, Inc. Ms. Woo received her undergraduate degree from the University of California, Berkeley and her MBA from Kellogg School of Management.
Ehemalige bekannte Positionen von Elizabeth Woo
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | - |
| POXEL | Investor Relations Contact | - |
Flex Pharma, Inc.
 Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Investor Relations Contact | - |
Ausbildung von Elizabeth Woo
| University of California, Berkeley | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| POXEL | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Health Technology |
